GXJ
WST icon

Global X Japan’s West Pharmaceutical WST Stock Holding History

Global X Japan’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$785K Sell
2,188
-207
-9% -$63.3K 0.03% 130
2026
Q1 		$600K Buy
2,395
+311
+15% +$77.4K 0.03% 150
2025
Q4 		$573K Sell
2,084
-114
-5% -$31.2K 0.04% 145
2025
Q3 		$577K Sell
2,198
-507
-19% -$123K 0.05% 129
2025
Q2 		$592K Buy
2,705
+950
+54% +$203K 0.06% 102
2025
Q1 		$393K Buy
1,755
+182
+12% +$50.2K 0.05% 123
2024
Q4 		$515K Buy
1,573
+270
+21% +$85K 0.06% 72
2024
Q3 		$391K Buy
1,303
+216
+20% +$66.1K 0.05% 121
2024
Q2 		$358K Sell
1,087
-99
-8% -$35K 0.05% 119
2024
Q1 		$469K Buy
1,186
+279
+31% +$103K 0.1% 64
2023
Q4 		$319K Buy
+907
New +$321K 0.18% 105

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Global X Japan's WST Position: Q2 2026 in Review

Global X Japan reduced its West Pharmaceutical (WST) stake by 8.6% in Q2 2026, selling an estimated $63.3K and leaving 2,188 shares worth $785K. The position accounts for 0.03% of the portfolio, ranked #130.

Global X Japan first reported a position in WST in Q4 2023 and has held it in 11 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Global X Japan held 2,188 shares of West Pharmaceutical worth $785K as of Q2 2026.
  • Global X Japan sold 207 West Pharmaceutical shares in Q2 2026, an estimated $63.3K.
  • West Pharmaceutical made up 0.03% of Global X Japan's portfolio in Q2 2026, its #130 holding.
  • Global X Japan first reported a position in West Pharmaceutical in Q4 2023 and has held it in 11 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Global X Japan's 13F filing for Q2 2026, filed 14 Jul 2026.